November 19, 2024

MASLD Affects 42% of US Adults, Study Finds

A US-based study found Hispanic individuals had significantly higher metabolic dysfunction-associated steatotic liver disease prevalence at 47.0% compared to 40.7% in non-Hispanic whites, despite nearly half of all U.S. adults showing signs of fatty liver disease.

Conexiant

November 19, 2024

Does Earlier TDF Reduce HBV Transmission?

Conexiant

November 18, 2024

Skin Disease Signals Hidden Heart Risks

Psoriasis not only marks the skin but also significantly raises the risk of myocardial infarction, stroke, and cardiovascular death, highlighting an urgent need for cardiovascular screening in these patients.

Conexiant

November 18, 2024

Supreme Court Blocks Xifaxan Generic Entry

Reuters

November 13, 2024

Long-Term Autoimmune Risks After COVID-19

Conexiant

November 12, 2024

FDA Denies Full Approval for Intercept’s Liver Drug

Reuters

November 11, 2024

Perirenal Fat Predicts Metabolic Syndrome Risk

A study revealed a strong association between perirenal fat thickness and metabolic syndrome risk, suggesting the potential of MRI-assessed perirenal fat thickness as a risk assessment component.

Conexiant

November 07, 2024

Zinc: Missing Link in HE Management?

Study reveals stark survival contrast: cirrhotic patients with normal zinc levels showed 86% survival rate versus significantly poorer outcomes in zinc-deficient patients (35.56 ± 11.65 mcg/dL, P<.0001), suggesting a potentially modifiable risk factor in hepatic encephalopathy management.

Conexiant

November 07, 2024

New HCC Risk Score May Improve Screening for Adults Without Viral Hepatitis

A recent study developed a risk score to identify hepatocellular carcinoma in adults without viral hepatitis or advanced fibrosis, using data from 6.5 million veterans. The risk score showed improved discrimination, particularly in identifying patients at higher risk without viral hepatitis or cirrhosis.

Conexiant